Delivery Order SPE2DB24D3013-SPE2DB25FFFMZ

Award Date 10/7/24
Potential Completion Date 10/8/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,741.68 and a completion date of July 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $2,252.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of April 22, 2025. It is not designated as a set-aside contract, indicating...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies. The $6,993.36 firm fixed-price delivery order is for the supply of Trulicity 0.75 mg/0.5 ml pens, a prescription medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 11, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,506.36 delivery order contract is for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of October 31, 2024 and is a firm fixed-price arrangement. This award is part of AmerisourceBergen's larger $999,999,999 Indefinite Delivery...
This federal contract award, valued at $3,710.61, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of April 2, 2025 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat type 2 diabetes. The award, valued at $1,280.50, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through...
This federal contract award, valued at $1,380.57, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract has an ultimate completion date of December 4, 2024 and does not utilize any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is the...
This federal contract award, valued at $2,252.25, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 1.5 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. The contract is a delivery order with a firm fixed price and an ultimate completion date of April 7, 2025. It is not designated as a set-aside contract, indicating open competition....
This federal contract award, valued at $1,951.95, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of diabetes. The contract has an ultimate completion date of November 27, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation, indicating this was an open...
This federal contract award, valued at $10,899.32, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pens, a medication used to manage diabetes. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFFMZ
    Delivery Order

This federal contract award, valued at $2,902.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company. The contract is for the delivery of Trulicity 0.75 mg/0.5 ml pen 0.5 ml, a medication used to treat diabetes. It is a firm-fixed-price delivery order contract with an ultimate completion date of October 8, 2024.

The contract is not associated with a set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for supplying the pharmaceutical product to support the DLA's medical requirements. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which enables the agency to efficiently procure a comprehensive range of medical commodities, including prescription drugs, to support military treatment programs and facilities worldwide.

Generated 1/6/25, 12:31 PM